Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization
Jan
2
2018
New Year's Resolutions For The U.S. Patent System Foley & Lardner LLP
Dec
29
2017
PTO Litigation Report – December 29, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Dec
29
2017
USITC Denies Entry into Early Disposition Pilot Program for Three More Cases Squire Patton Boggs (US) LLP
Dec
28
2017
Reverse Engineered Podcast: Episode 11 | Part 1: Buy, Sell or Hodl: The Patent Side of Cryptocurrency and Blockchain Technologies McDermott Will & Emery
Dec
28
2017
Anticipation Bounces Back Electronic Return Receipt Patent as Invalid Proskauer Rose LLP
Dec
28
2017
PTO Litigation Report – December 28, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Dec
28
2017
Assertion of Patents Results in Loss of Sovereign Immunity for Public Universities Mintz
Dec
27
2017
PTO Litigation Report – December 27, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Dec
27
2017
Trademark Practice Update: Scandalous? Immoral? It's all Good Sterne, Kessler, Goldstein & Fox P.L.L.C.
Dec
27
2017
Ultra Violet is the New Black Sterne, Kessler, Goldstein & Fox P.L.L.C.
Dec
26
2017
Cesari S.R.L. v. Peju Province Winery L.P.: Relying on Supreme Court Precedent, District Court Holds that Trademark Trial & Appeal Board Finding of Likelihood of Confusion has Preclusive Effect Sheppard, Mullin, Richter & Hampton LLP
Dec
25
2017
When A Musical Misstep By Disney Means Millions, It’s Hard To "Let It Go!" IMS Legal Strategies
Dec
25
2017
Aqua Products Sinks PTAB Decision in Bosch v. Matal Schwegman, Lundberg & Woessner, P.A.
Dec
22
2017
European Commission Reminds Trademark Owners to Prepare for Brexit, Warning EU Protection May No Longer Extend to UK as of March 30, 2019 Dinsmore & Shohl LLP
Dec
22
2017
Empire Strikes Back: First Amendment Protects TV Series Title McDermott Will & Emery
Dec
22
2017
The Board Gives Section 325(d) Sharp Teeth—Part III —Things Are Looking Up for Patent Owners Sterne, Kessler, Goldstein & Fox P.L.L.C.
Dec
22
2017
Presumption in Favor of Unmasking Copyright Infringers McDermott Will & Emery
Dec
22
2017
Newsletter Sent to US Customers Insufficient to Establish Personal Jurisdiction McDermott Will & Emery
Dec
22
2017
Winter Fest Trademark Fight Gets Frosty McDermott Will & Emery
Dec
22
2017
Two Federal Preemption Cases, One Consistent Outcome McDermott Will & Emery
Dec
22
2017
PTAB Explains Procedure for Handling Remand from Federal Circuit McDermott Will & Emery
Dec
22
2017
Looking Back: TC Heartland Is a Change of Law McDermott Will & Emery
Dec
22
2017
Discussion of Read Factors Not Mandatory for Enhanced Damages Determination McDermott Will & Emery
Dec
22
2017
Unclaimed Features Cannot Save Eligibility of Claims McDermott Will & Emery
Dec
22
2017
Totality of Evidence Must Be Considered in Assessing Obviousness McDermott Will & Emery
Dec
22
2017
No Second Chances for Promega Damages Claim McDermott Will & Emery
Dec
22
2017
The Turning Tide of Adoption of the Lead Compound Analysis Is Favoring Patent Owners at the PTAB Sterne, Kessler, Goldstein & Fox P.L.L.C.
Dec
22
2017
Indefiniteness Standard Less Strict Where Claim Term Does Not Concern Point of Novelty McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins